These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1924892)

  • 1. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
    Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
    Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
    Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
    Sandvik AK; Waldum HL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion.
    Konturek SJ; Bilski J; Cieszkowski M
    Regul Pept; 1992 Nov; 42(1-2):97-109. PubMed ID: 1475410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats.
    Varga G; Campbell DR; Bussjaeger LJ; Solomon TE
    Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
    Hirst BH; Elliott KJ; Ryder H; Szelke M
    Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
    Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
    Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R; Ding XQ; Norlén P; Lindström E
    Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H; Debas HT; Bunnett NW
    Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between activation of ornithine decarboxylase and histidine decarboxylase in rat stomach.
    Ding XQ; Chen D; Rosengren E; Persson L; Hakanson R
    Am J Physiol; 1996 Mar; 270(3 Pt 1):G476-86. PubMed ID: 8638714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.